ZARNESTRA
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for ZARNESTRA, covering 2006-11-14 to 2015-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]